These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 37676963)

  • 1. Neurodegeneration enters the era of functional genomics.
    Aguzzi A; Kampmann M
    Science; 2023 Sep; 381(6662):eadk5693. PubMed ID: 37676963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Progress in lentiviral vector-mediated gene therapy for Alzheimer's disease and Parkinson's disease].
    Xu D; Liu L; Lang M
    Sheng Wu Gong Cheng Xue Bao; 2020 Dec; 36(12):2707-2718. PubMed ID: 33398966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Approaches for the Treatment of Alzheimer's and Parkinson's Disease.
    Van Bulck M; Sierra-Magro A; Alarcon-Gil J; Perez-Castillo A; Morales-Garcia JA
    Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30743990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Common Factors in Neurodegeneration: A Meta-Study Revealing Shared Patterns on a Multi-Omics Scale.
    Ruffini N; Klingenberg S; Schweiger S; Gerber S
    Cells; 2020 Dec; 9(12):. PubMed ID: 33302607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacoepigenomic Interventions as Novel Potential Treatments for Alzheimer's and Parkinson's Diseases.
    Teijido O; Cacabelos R
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30332838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current Aspects of the Endocannabinoid System and Targeted THC and CBD Phytocannabinoids as Potential Therapeutics for Parkinson's and Alzheimer's Diseases: a Review.
    Cooray R; Gupta V; Suphioglu C
    Mol Neurobiol; 2020 Nov; 57(11):4878-4890. PubMed ID: 32813239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy for Parkinson's disease.
    Schwab AD; Thurston MJ; Machhi J; Olson KE; Namminga KL; Gendelman HE; Mosley RL
    Neurobiol Dis; 2020 Apr; 137():104760. PubMed ID: 31978602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene- and cell-based approaches for neurodegenerative disease.
    Urbaniak Hunter K; Yarbrough C; Ciacci J
    Adv Exp Med Biol; 2010; 671():117-30. PubMed ID: 20455500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding Epigenetic Alterations in Alzheimer's and Parkinson's Disease: Towards Targeted Biomarkers and Therapies.
    Ciceri F; Rotllant D; Maes T
    Curr Pharm Des; 2017; 23(5):839-857. PubMed ID: 28120717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shared mechanisms of neurodegeneration in Alzheimer's disease and Parkinson's disease.
    Xie A; Gao J; Xu L; Meng D
    Biomed Res Int; 2014; 2014():648740. PubMed ID: 24900975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic insights into immune mechanisms of Alzheimer's and Parkinson's disease.
    Nott A; Holtman IR
    Front Immunol; 2023; 14():1168539. PubMed ID: 37359515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene therapy for Parkinson's and Alzheimer's diseases: from the bench to clinical trials.
    Nobre RJ; Almeida LP
    Curr Pharm Des; 2011; 17(31):3434-45. PubMed ID: 21902665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of microRNA-485 in neurodegenerative diseases.
    Ryu IS; Kim DH; Cho HJ; Ryu JH
    Rev Neurosci; 2023 Jan; 34(1):49-62. PubMed ID: 35793556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Long Non-coding RNAs in the Pathogenesis of Alzheimer's and Parkinson's Diseases.
    Sivagurunathan N; Ambatt ATS; Calivarathan L
    Curr Aging Sci; 2022; 15(2):84-96. PubMed ID: 35081899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Precision medicine: Clarity for the clinical and biological complexity of Alzheimer's and Parkinson's diseases.
    Montine TJ; Montine KS
    J Exp Med; 2015 May; 212(5):601-5. PubMed ID: 25941321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying the Association Between Alzheimer's Disease and Parkinson's Disease Using Genome-Wide Association Studies and Protein-Protein Interaction Network.
    Liu G; Bao X; Jiang Y; Liao M; Jiang Q; Feng R; Zhang L; Ma G; Chen Z; Wang G; Wang R; Zhao B; Li K
    Mol Neurobiol; 2015 Dec; 52(3):1629-1636. PubMed ID: 25370933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. mtDNA mutations and common neurodegenerative disorders.
    Howell N; Elson JL; Chinnery PF; Turnbull DM
    Trends Genet; 2005 Nov; 21(11):583-6. PubMed ID: 16154228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting Age-Related Neurodegenerative Diseases by AAV-Mediated Gene Therapy.
    Cagin U
    Adv Exp Med Biol; 2021; 1286():213-223. PubMed ID: 33725356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neural regeneration therapies for Alzheimer's and Parkinson's disease-related disorders.
    Reddy AP; Ravichandran J; Carkaci-Salli N
    Biochim Biophys Acta Mol Basis Dis; 2020 Apr; 1866(4):165506. PubMed ID: 31276770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.